Charlie de Lanoy Meijer

Charlie de Lanoy Meijer has extensive experience in sales and research within various industries, currently serving as a Sales Development Representative at Beacon Targeted Therapies since November 2022. In this role, Charlie supports biotechs and pharmaceutical companies by providing insights through a comprehensive database to help inform strategic decisions. Previously, Charlie worked as a Delegate Sales Executive at Hanson Wade and as a Researcher at flypop, focusing on sustainable fuel policies. Additional experience includes internships and short-term roles in sales and production, alongside a solid academic background in Biology from the University of Bristol, specializing in Genetics, Molecular Biology, and Ecology.